Figure 7
From: Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
Nifuroxazide reduced MDSCs (Gr1+CD11b+) infiltration in lung sections.
FCM was used to analyze the expression of MDSCs. The MDSCs were isolated from the lungs of experimental melanoma metastasis model mice treated with vehicle (a), or treated with nifuroxazide at 50 mg/kg (b), or normal mice (c) using as negative contrast. (d) Statistic results of each group were shown. Values represented mean ± SD (n = 6, ***P < 0.001).
